As of 2025-09-16, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.08 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.36 CAD, the upside of Newscope Capital Corporation is -123.52%.
Based on its market price of 0.36 CAD and our intrinsic valuation, Newscope Capital Corporation (PHRM.CN) is overvalued by 123.52%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.08 - -0.08 | -0.08 | -123.52% |
| P/E | (0.01) - (0.10) | (0.01) | -102.6% |
| DDM - Stable | (0.16) - 6.13 | 2.98 | 740.2% |
| DDM - Multi | (0.18) - 5.64 | (0.39) | -210.1% |
| Market Cap (mil) | 31.42 |
| Beta | 1.03 |
| Outstanding shares (mil) | 88.52 |
| Enterprise Value (mil) | 30.20 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.44% |
| Cost of Debt | 5.00% |
| WACC | 5.57% |